Cilnidipine

Cilnidipine has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Feb 9, 2026: “Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy…”.

1 paper studies it1 more mentions itUpdated Feb 9, 2026

See all 2 papers on cilnidipine

At a glance

2 trials, none about aging, 2 with no results posted.

2 trials, none about aging, 2 with no results posted

2 of 2 trials sponsored by its developers

Trial sponsors

IlDong Pharmaceutical
Company2 trialsPhase 3340 people

Latest

1 paper in 12 months

CureusMar 16

Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy With Reference to Telmisartan and Cilnidipine

ReviewTelmisartan

Science SignalingNov 15

Hypoxia-induced interaction of filamin with Drp1 causes mitochondrial hyperfission-associated myocardial senescence

Experiments in animalsMechanisms